Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

NCT01014325 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
130
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Roxall Medizin